Moderna, Inc. (MRNA)
Moderna Market Cap: 16.25B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 954.99B |
| Merck & Co., Inc. | 268.73B |
| Pfizer Inc. | 143.56B |
| Novavax, Inc. | 1.296B |
| Johnson & Johnson | 523.47B |
Market Cap Related Metrics
| PS Ratio | 7.214 |
| PEG Ratio | -0.1341 |
| Price to Book Value | 1.741 |
| Price | 41.58 |
| Earnings Yield | -19.39% |
| PEGY Ratio | -0.1341 |